The application of the CRISPR-Cas system in antibiotic resistance

Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage

Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437 · see citing works

Nucleic acid detection with CRISPR-Cas13a/C2c2

Gootenberg, J. S., Abudayyeh, O. O., Lee, J. W., Essletzbichler, P., Dy, A. J., Joung, J., Verdine, V. K., Donghia, N. M., Daringer, N. M., Freije, C. A., et al. (2017) · Science · doi:10.1126/science.aam9321 · Cited by 3,887 · see citing works

Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria

Gasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208507109 · Cited by 2,769 · see citing works

An updated evolutionary classification of CRISPR–Cas systems

Makarova, K. S., Wolf, Y. I., Alkhnbashi, O. S., Costa, F., Shah, S. A., Saunders, S. J., Barrangou, R., Brouns, S. J. J., Charpentier, E., Haft, D. H., et al. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3569 · Cited by 2,504 · see citing works

Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies

Pang, Z., Raudonis, R., Glick, B. R., Lin, T., & Cheng, Z. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,375 · see citing works

Crystal structure of Cas9 in complex with guide RNA and target DNA

Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O. (2014) · Cell · doi:10.1016/j.cell.2014.02.001 · Cited by 2,306 · see citing works

Dissemination of Antimicrobial Resistance in Microbial Ecosystems through Horizontal Gene Transfer

von Wintersdorff, C. J. H., Penders, J., van Niekerk, J. M., Mills, N. D., Majumder, S., van Alphen, L. B., Savelkoul, P. H. M., & Wolffs, P. F. G. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00173 · Cited by 1,707 · see citing works

Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens

Santajit, S., & Indrawattana, N. (2016) · BioMed Research International · doi:10.1155/2016/2475067 · Cited by 1,669 · see citing works

The next generation of CRISPR–Cas technologies and applications

Pickar-Oliver, A., & Gersbach, C. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0131-5 · Cited by 1,459 · see citing works

Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems

Shmakov, S., Abudayyeh, O. O., Makarova, K. S., Wolf, Y. I., Gootenberg, J. S., Semenova, E., Станиславович, М. Л., Joung, J., Konermann, S., Severinov, K., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.008 · Cited by 1,221 · see citing works

Delivering CRISPR: a review of the challenges and approaches

Lino, C. A., Harper, J. C., Carney, J. P., & Timlin, J. A. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1474964 · Cited by 1,185 · see citing works

Environmental factors influencing the development and spread of antibiotic resistance

Bengtsson-Palme, J., Kristiansson, E., & Larsson, D. G. J. (2018) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux053 · Cited by 1,167 · see citing works

Diversity and evolution of class 2 CRISPR–Cas systems

Shmakov, S., Smargon, A. A., Scott, D. A., Cox, D. B. T., Pyzocha, N., Yan, W. X., Abudayyeh, O. O., Gootenberg, J. S., Makarova, K. S., Wolf, Y. I., et al. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.184 · Cited by 1,056 · see citing works

The Biology of CRISPR-Cas: Backward and Forward

Hille, F., Richter, H., Wong, S. P., Bratovič, M., Ressel, S., & Charpentier, E. (2018) · Cell · doi:10.1016/j.cell.2017.11.032 · Cited by 1,019 · see citing works

CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes

Komor, A. C., Badran, A. H., & Liu, D. R. (2016) · Cell · doi:10.1016/j.cell.2016.10.044 · Cited by 1,011 · see citing works

Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials

Bikard, D., Euler, C. W., Jiang, W., Nussenzweig, P. M., Goldberg, G. W., Duportet, X., Fischetti, V. A., & Marraffini, L. A. (2014) · Nature Biotechnology · doi:10.1038/nbt.3043 · Cited by 986 · see citing works

Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and Persistence

Christaki, E., Marcou, M., & Tofarides, A. G. (2019) · Journal of Molecular Evolution · doi:10.1007/s00239-019-09914-3 · Cited by 818 · see citing works

Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance

Uruén, C., Chopo‐Escuin, G., Tommassen, J., Jaime, R. C. M., & Arenas, J. (2020) · Antibiotics · doi:10.3390/antibiotics10010003 · Cited by 812 · see citing works

Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems

Mohanraju, P., Makarova, K. S., Zetsche, B., Zhang, F., Koonin, E. V., & John van der, O. O. S. T. (2016) · Science · doi:10.1126/science.aad5147 · Cited by 668 · see citing works

Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy

Oechslin, F. (2018) · Viruses · doi:10.3390/v10070351 · Cited by 605 · see citing works

Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options

Sheu, C., Chang, Y.-T., Lin, S., Chen, Y., & Hsueh, P. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00080 · Cited by 534 · see citing works

CRISPR Immunity Relies on the Consecutive Binding and Degradation of Negatively Supercoiled Invader DNA by Cascade and Cas3

Westra, E. R., van Erp, P. B. G., Künne, T., Wong, S. P., Staals, R. H. J., Seegers, C. L. C., Bollen, S., Jore, M. M., Semenova, E., Severinov, K., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.03.018 · Cited by 511 · see citing works

CRISPR-Cas: biology, mechanisms and relevance

Hille, F., & Charpentier, E. (2016) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2015.0496 · Cited by 503 · see citing works

Enhanced Efficiency of Human Pluripotent Stem Cell Genome Editing through Replacing TALENs with CRISPRs

Ding, Q., Regan, S. N., Xia, Y., Oostrom, L. A., Cowan, C. A., & Musunuru, K. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.03.006 · Cited by 502 · see citing works

Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria

Yosef, I., Manor, M., Kiro, R., & Qimron, U. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500107112 · Cited by 501 · see citing works

Mechanisms of antimicrobial resistance in Gram-negative bacilli

Ruppé, É., Woerther, P., & Barbier, F. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0061-0 · Cited by 500 · see citing works

Cas1–Cas2 complex formation mediates spacer acquisition during CRISPR–Cas adaptive immunity

Nuñez, J. K., Kranzusch, P. J., Noeske, J., Wright, A. V., Davies, C., & Doudna, J. A. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2820 · Cited by 458 · see citing works

CRISPR-Cas systems: Overview, innovations and applications in human disease research and gene therapy

Xu, Y., & Li, Z. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.08.031 · Cited by 424 · see citing works

CRISPR-Cas: Adapting to change

Jackson, S. A., McKenzie, R. E., Fagerlund, R. D., Kieper, S. N., Fineran, P. C., & Brouns, S. J. J. (2017) · Science · doi:10.1126/science.aal5056 · Cited by 395 · see citing works

Self-medication and antibiotic resistance: Crisis, current challenges, and prevention

Rather, I. A., Kim, B.-C., Bajpai, V. K., & Park, Y.-H. (2017) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2017.01.004 · Cited by 382 · see citing works

Plasmid-mediated horizontal gene transfer is a coevolutionary process

Harrison, E., & Brockhurst, M. A. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2012.04.003 · Cited by 366 · see citing works

Multiple mechanisms for CRISPR–Cas inhibition by anti-CRISPR proteins

Bondy‐Denomy, J., Garcı́a, B., Strum, S. W., Du, M., Rollins, M. F., Hidalgo-Reyes, Y., Wiedenheft, B., Maxwell, K. L., & Davidson, A. R. (2015) · Nature · doi:10.1038/nature15254 · Cited by 356 · see citing works

Integrase-mediated spacer acquisition during CRISPR–Cas adaptive immunity

Nuñez, J. K., Lee, A. S. Y., Engelman, A., & Doudna, J. A. (2015) · Nature · doi:10.1038/nature14237 · Cited by 337 · see citing works

Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party†

Hawkey, P. M., Warren, R. E., Livermore, D. M., McNulty, C. A. M., Enoch, D., Otter, J. A., & Wilson, A. P. R. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky027 · Cited by 331 · see citing works

Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species

Pawluk, A., Staals, R. H. J., Taylor, C., Watson, B. N. J., Saha, S., Fineran, P. C., Maxwell, K. L., & Davidson, A. R. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.85 · Cited by 312 · see citing works

Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment

Xu, X., Liu, C., Wang, Y., Koivisto, O., Zhou, J., Shu, Y., & Zhang, H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113891 · Cited by 295 · see citing works

Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity

Charpentier, E., Richter, H., John van der, O. O. S. T., & White, M. F. (2015) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv023 · Cited by 292 · see citing works

Towards an integrated model of bacterial conjugation

Cabezón, E., Ripoll‐Rozada, J., Peña, A., de la Cruz, F., & Aréchaga, I. (2014) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12085 · Cited by 288 · see citing works

Plant genome editing with TALEN and CRISPR

Malzahn, A. A., Lowder, L. G., & Qi, Y. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0148-4 · Cited by 280 · see citing works

Phage as a Modulator of Immune Responses

Górski, A., Międzybrodzki, R., Borysowski, J., Dąbrowska, K., Wierzbicki, P., Kniotek, M., Korczak-Kowalska, G., Olszowska-Zaremba, N., Łusiak-Szelachowska, M., Kłak, M., et al. (2012) · Advances in virus research · doi:10.1016/b978-0-12-394438-2.00002-5 · Cited by 268 · see citing works

A New Group of Phage Anti-CRISPR Genes Inhibits the Type I-E CRISPR-Cas System of Pseudomonas aeruginosa

Pawluk, A., Bondy‐Denomy, J., Cheung, V. H. W., Maxwell, K. L., & Davidson, A. R. (2014) · mBio · doi:10.1128/mbio.00896-14 · Cited by 263 · see citing works

Interaction between Bacteriophage DMS3 and Host CRISPR Region Inhibits Group Behaviors ofPseudomonas aeruginosa

Zegans, M. E., Wagner, J. C., Cady, K. C., Murphy, D. M., Hammond, J. H., & O’Toole, G. A. (2008) · Journal of Bacteriology · doi:10.1128/jb.00797-08 · Cited by 255 · see citing works

A Broad-Spectrum Inhibitor of CRISPR-Cas9

Harrington, L. B., Doxzen, K. W., Ma, E., Liu, J., Knott, G. J., Edraki, A., Garcı́a, B., Amrani, N., Chen, J. S., Cofsky, J. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.037 · Cited by 254 · see citing works

Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria

Kiga, K., Tan, X.-E., Ibarra‐Chávez, R., Watanabe, S., Aiba, Y., Sato’o, Y., Li, F.-Y., Sasahara, T., Cui, B., Kawauchi, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16731-6 · Cited by 245 · see citing works

CRISPR-Cas9 and CRISPR-Assisted Cytidine Deaminase Enable Precise and Efficient Genome Editing in Klebsiella pneumoniae

Wang, Y., Wang, S., Chen, W., Song, L., Zhang, Y., Shen, Z., Yu, F., Li, M., & Ji, Q. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.01834-18 · Cited by 243 · see citing works

Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies

Marino, N. D., Pinilla‐Redondo, R., Csörgő, B., & Bondy‐Denomy, J. (2020) · Nature Methods · doi:10.1038/s41592-020-0771-6 · Cited by 240 · see citing works

The Discovery, Mechanisms, and Evolutionary Impact of Anti-CRISPRs

Borges, A. L., Davidson, A. R., & Bondy‐Denomy, J. (2017) · Annual Review of Virology · doi:10.1146/annurev-virology-101416-041616 · Cited by 215 · see citing works

Nonviral Genome Editing Based on a Polymer-Derivatized CRISPR Nanocomplex for Targeting Bacterial Pathogens and Antibiotic Resistance

Kang, Y. K., Kwon, K., Ryu, J. S., Lee, H. N., Park, C., & Chung, H. J. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00676 · Cited by 210 · see citing works

Structure Reveals Mechanisms of Viral Suppressors that Intercept a CRISPR RNA-Guided Surveillance Complex

Chowdhury, S., Carter, J. J., Rollins, M. F., Golden, S. M., Jackson, R. N., Hoffmann, C., Nosaka, L., Bondy‐Denomy, J., Maxwell, K. L., Davidson, A. R., et al. (2017) · Cell · doi:10.1016/j.cell.2017.03.012 · Cited by 210 · see citing works

Application of different types of CRISPR/Cas-based systems in bacteria

Liu, Z., Dong, H., Cui, Y., Cong, L., & Zhang, D. (2020) · Microbial Cell Factories · doi:10.1186/s12934-020-01431-z · Cited by 204 · see citing works

Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editing

Yao, X., Lyu, P., Yoo, K. W., Yadav, M., Singh, R. N., Atala, A., & Lu, B. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12076 · Cited by 197 · see citing works

Efficient programmable gene silencing by Cascade

Rath, D., Amlinger, L., Hoekzema, M., Devulapally, P. R., & Lundgren, M. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1257 · Cited by 189 · see citing works

Cryo-EM Structures Reveal Mechanism and Inhibition of DNA Targeting by a CRISPR-Cas Surveillance Complex

Guo, T. W., Bartesaghi, A., Yang, H., Falconieri, V., Rao, P., Merk, A., Eng, E. T., Raczkowski, A. M., Fox, T. L., Earl, L. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.006 · Cited by 184 · see citing works

Dynamics and competition of CRISPR–Cas9 ribonucleoproteins and AAV donor-mediated NHEJ, MMEJ and HDR editing

Fu, Y.-W., Dai, X., Wang, W., Yang, Z.-X., Zhao, J.-J., Zhang, J., Wen, W., Zhang, F., Oberg, K. C., Zhang, L., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1251 · Cited by 176 · see citing works

SnapShot: Class 1 CRISPR-Cas Systems

Makarova, K. S., Zhang, F., & Koonin, E. V. (2017) · Cell · doi:10.1016/j.cell.2017.02.018 · Cited by 173 · see citing works

Conjugative Delivery of CRISPR-Cas9 for the Selective Depletion of Antibiotic-Resistant Enterococci

Rodrigues, M., McBride, S. W., Hullahalli, K., Palmer, K. L., & Duerkop, B. A. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01454-19 · Cited by 173 · see citing works

Phage-delivered CRISPR-Cas9 for strain-specific depletion and genomic deletions in the gut microbiome

Lam, K. N., Spanogiannopoulos, P., Soto-Perez, P., Alexander, M., Nalley, M. J., Bisanz, J. E., Nayak, R. R., Weakley, A. M., Yu, F. B., & Turnbaugh, P. J. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109930 · Cited by 172 · see citing works

How CRISPR-Cas System Could Be Used to Combat Antimicrobial Resistance

Gholizadeh, P., Köse, Ş., Dao, S., Ganbarov, K., Tanomand, A., Dal, T., Aghazadeh, M. H., Ghotaslou, R., Rezaee, M. A., Yousefi, B., et al. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s247271 · Cited by 170 · see citing works

Mobile Genetic Elements and Evolution of CRISPR-Cas Systems: All the Way There and Back

Koonin, E. V., & Makarova, K. S. (2017) · Genome Biology and Evolution · doi:10.1093/gbe/evx192 · Cited by 166 · see citing works

Engineered CRISPR-Cas systems for the detection and control of antibiotic-resistant infections

Wu, Y., Battalapalli, D., Hakeem, M. J., Selamneni, V., Zhang, P., Draz, M. S., & Ruan, Z. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01132-8 · Cited by 152 · see citing works

Type II-C CRISPR-Cas9 Biology, Mechanism, and Application

Mir, A., Edraki, A., Lee, J., & Sontheimer, E. J. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00855 · Cited by 148 · see citing works

Antibody‐mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen

Fantappiè, L., Santis, M. D., Chiarot, E., Carboni, F., Bensi, G., Jousson, O., Margarit, I., & Grandi, G. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.24015 · Cited by 147 · see citing works

Non-Identity-Mediated CRISPR-Bacteriophage Interaction Mediated via the Csy and Cas3 Proteins

Cady, K. C., & O’Toole, G. A. (2011) · Journal of Bacteriology · doi:10.1128/jb.01411-10 · Cited by 145 · see citing works

Phage-Encoded Anti-CRISPR Defenses

Stanley, S. Y., & Maxwell, K. L. (2018) · Annual Review of Genetics · doi:10.1146/annurev-genet-120417-031321 · Cited by 142 · see citing works

CRISPR-Cas in Streptococcus pyogenes

Rhun, A. L., Escalera-Maurer, A., Bratovič, M., & Charpentier, E. (2019) · RNA Biology · doi:10.1080/15476286.2019.1582974 · Cited by 137 · see citing works

CRISPR/Cas9-Mediated Re-Sensitization of Antibiotic-Resistant Escherichia coli Harboring Extended-Spectrum ��-Lactamases

Kim, J., Cho, D.-H., Park, M., Chung, W.-J., Shin, D., Ko, K. S., & Kweon, D. (2016) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1508.08080 · Cited by 133 · see citing works

Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics

Givens, B. E., Naguib, Y. W., Geary, S. M., Devor, E. J., & Salem, A. K. (2018) · The AAPS Journal · doi:10.1208/s12248-018-0267-9 · Cited by 132 · see citing works

CRISPR-Cas and Restriction-Modification Act Additively against Conjugative Antibiotic Resistance Plasmid Transfer in Enterococcus faecalis

Price, V. J., Huo, W., Sharifi, A., & Palmer, K. L. (2016) · mSphere · doi:10.1128/msphere.00064-16 · Cited by 132 · see citing works

CRISPR-Cas9-Mediated Carbapenemase Gene and Plasmid Curing in Carbapenem-Resistant Enterobacteriaceae

Hao, M., He, Y., Zhang, H., Liao, X., Liu, Y.-H., Sun, J. G., Du, H., Kreiswirth, B. N., & Chen, L. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00843-20 · Cited by 124 · see citing works

CRISPR-Cas systems are present predominantly on mobile genetic elements in Vibrio species

McDonald, N. D., Regmi, A., Morreale, D. P., Borowski, J. D., & Boyd, E. F. (2019) · BMC Genomics · doi:10.1186/s12864-019-5439-1 · Cited by 123 · see citing works

No evidence of inhibition of horizontal gene transfer by CRISPR–Cas on evolutionary timescales

Gophna, U., Kristensen, D. M., Wolf, Y. I., Popa, O., Drevet, C., & Koonin, E. V. (2015) · The ISME Journal · doi:10.1038/ismej.2015.20 · Cited by 119 · see citing works

Protospacer adjacent motif (PAM)-distal sequences engage CRISPR Cas9 DNA target cleavage

Cencic, R., Miura, H., Malina, A., Robert, F., Ethier, S., Schmeing, T. M., Dostie, J., & Pelletier, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109213 · Cited by 117 · see citing works

A phage-encoded anti-CRISPR enables complete evasion of type VI-A CRISPR-Cas immunity

Meeske, A. J., Jia, N., Cassel, A. K., Kozlova, A., Liao, J., Wiedmann, M., Patel, D. J., & Marraffini, L. A. (2020) · Science · doi:10.1126/science.abb6151 · Cited by 114 · see citing works

CRISPR-cas system: biological function in microbes and its use to treat antimicrobial resistant pathogens

Shabbir, M. A. B., Shabbir, M. Z., Wu, Q., Mahmood, S., Sajid, A., Maan, M. K., Ahmed, S., Chaudhry, U. N., Hao, H., & Yuan, Z. (2019) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-019-0317-x · Cited by 113 · see citing works

Sheep and Goat Genome Engineering: From Random Transgenesis to the CRISPR Era

Kalds, P., Zhou, S., Cai, B., Liu, J., Wang, Y., Petersen, B., Sonstegard, T. S., Wang, X., & Chen, Y. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00750 · Cited by 112 · see citing works

Gene mobility promotes the spread of resistance in bacterial populations

Stevenson, C., Hall, J. P. J., Harrison, E., Wood, A. J., & Brockhurst, M. A. (2017) · The ISME Journal · doi:10.1038/ismej.2017.42 · Cited by 112 · see citing works

Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transfer

Mahendra, C., Christie, K. A., Osuna, B. A., Pinilla‐Redondo, R., Kleinstiver, B. P., & Bondy‐Denomy, J. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0692-2 · Cited by 111 · see citing works

First indication for a functional CRISPR/Cas system in Francisella tularensis

Schunder, E., Rydzewski, K., Grunow, R., & Heuner, K. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2012.11.004 · Cited by 111 · see citing works

DNA and RNA interference mechanisms by CRISPR-Cas surveillance complexes

Plagens, A., Richter, H., Charpentier, E., & Randau, L. (2015) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv019 · Cited by 110 · see citing works

Gene Transfer Potential of Outer Membrane Vesicles of Gram-Negative Bacteria

Dell’Annunziata, F., Folliero, V., Giugliano, R., Filippis, A. D., Santarcangelo, C., Izzo, V., Daglia, M., Galdiero, M., Arciola, C. R., & Franci, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115985 · Cited by 109 · see citing works

Nanoparticles as carriers of proteins, peptides and other therapeutic molecules

Pudlarz, A. M., & Szemraj, J. (2018) · Open Life Sciences · doi:10.1515/biol-2018-0035 · Cited by 108 · see citing works

Improving the efficiency of precise genome editing with site-specific Cas9-oligonucleotide conjugates

Ling, X., Xie, B., Gao, X., Chang, L., Zheng, W., Chen, H., Huang, Y., Tan, L., Li, M., & Liu, T. (2020) · Science Advances · doi:10.1126/sciadv.aaz0051 · Cited by 108 · see citing works

Plasmid-Mediated Transfer of Antibiotic Resistance Genes in Soil

Meng, M., Li, Y., & Yao, H. (2022) · Antibiotics · doi:10.3390/antibiotics11040525 · Cited by 108 · see citing works

Environmental DNA-Encoded Antibiotics Fasamycins A and B Inhibit FabF in Type II Fatty Acid Biosynthesis

Feng, Z., Chakraborty, D., Dewell, S. B., Reddy, B. V. B., & Brady, S. F. (2012) · Journal of the American Chemical Society · doi:10.1021/ja207662w · Cited by 107 · see citing works

A CRISPR-Cas system enhances envelope integrity mediating antibiotic resistance and inflammasome evasion

Sampson, T. R., Napier, B. A., Schroeder, M. R., Louwen, R., Zhao, J., Chin, C., Ratner, H. K., Llewellyn, A. C., Jones, C. L., Laroui, H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323025111 · Cited by 105 · see citing works

Novel Strategy to Combat Antibiotic Resistance: A Sight into the Combination of CRISPR/Cas9 and Nanoparticles

Wan, F., Draz, M. S., Gu, M., Yu, W., Ruan, Z., & Luo, Q. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030352 · Cited by 103 · see citing works

Prospects for the Use of New Technologies to Combat Multidrug-Resistant Bacteria

de Lima, R., Fiol, F. D. S. D., & Balcão, V. M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00692 · Cited by 98 · see citing works

Bacterial Outer Membrane Vesicles as Antibiotic Delivery Vehicles

Collins, S. M., & Brown, A. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.733064 · Cited by 97 · see citing works

Gene drive inhibition by the anti-CRISPR proteins AcrIIA2 and AcrIIA4 in Saccharomyces cerevisiae

Basgall, E. M., Goetting, S. C., Goeckel, M. E., Giersch, R. M., Roggenkamp, E., Schrock, M. N., Halloran, M., & Finnigan, G. C. (2018) · Microbiology · doi:10.1099/mic.0.000635 · Cited by 95 · see citing works

Enterococcus faecalis CRISPR-Cas Is a Robust Barrier to Conjugative Antibiotic Resistance Dissemination in the Murine Intestine

Price, V. J., McBride, S. W., Hullahalli, K., Chatterjee, A., Duerkop, B. A., & Palmer, K. L. (2019) · mSphere · doi:10.1128/msphere.00464-19 · Cited by 95 · see citing works

Exploiting a conjugative CRISPR/Cas9 system to eliminate plasmid harbouring the mcr-1 gene from Escherichia coli

Dong, H., Xiang, H., Mu, D., Wang, D., & Wang, T. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.09.017 · Cited by 94 · see citing works

Structures and mechanisms of CRISPR RNA-guided effector nucleases

Nishimasu, H., & Nureki, O. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.11.013 · Cited by 93 · see citing works

Endogenous Type I CRISPR-Cas: From Foreign DNA Defense to Prokaryotic Engineering

Zheng, Y., Li, J., Wang, B., Han, J., Hao, Y., Wang, S., Ma, X., Yang, S., Ma, L., Li, Y., et al. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00062 · Cited by 92 · see citing works

Conjugation efficiency depends on intra and intercellular interactions between distinct plasmids: Plasmids promote the immigration of other plasmids but repress co-colonizing plasmids

Gama, J. A., Zilhão, R., & Dionísio, F. (2017) · Plasmid · doi:10.1016/j.plasmid.2017.08.003 · Cited by 91 · see citing works

Synergistic Antibacterial Effects of Chitosan-Caffeic Acid Conjugate against Antibiotic-Resistant Acne-Related Bacteria

Kim, J. A., Yu, D., Eom, S., Kim, S.-H., Oh, J., Jung, W., & Kim, Y. (2017) · Marine Drugs · doi:10.3390/md15060167 · Cited by 91 · see citing works

The prevalence of colistin resistance in Escherichia coli and Klebsiella pneumoniae isolated from food animals in China: coexistence of mcr-1 and bla NDM with low fitness cost

Wang, R., Liu, Y., Zhang, Q., Jin, L., Wang, Q., Zhang, Y., Wang, X., Hu, M., Li, L., Qi, J., et al. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.01.023 · Cited by 87 · see citing works

Antibiotic resistance plasmids spread among natural isolates of Escherichia coli in spite of CRISPR elements

Touchon, M., Charpentier, S., Pognard, D., Picard, B., Arlet, G., Rocha, E. P. C., Denamur, É., & Branger, C. (2012) · Microbiology · doi:10.1099/mic.0.060814-0 · Cited by 87 · see citing works

Prevalence and Antimicrobial Resistance of Enterococcus Species: A Retrospective Cohort Study in Italy

Boccella, M., Santella, B., Pagliano, P., Filippis, A. D., Casolaro, V., Galdiero, M., Borrelli, A., Capunzo, M., Boccia, G., & Franci, G. (2021) · Antibiotics · doi:10.3390/antibiotics10121552 · Cited by 85 · see citing works

Characterizing leader sequences of CRISPR loci

Alkhnbashi, O. S., Shah, S. A., Garrett, R. A., Saunders, S. J., Costa, F., & Backofen, R. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw454 · Cited by 82 · see citing works

Eliminating mcr-1-harbouring plasmids in clinical isolates using the CRISPR/Cas9 system

Wang, P., He, D., Li, B., Guo, Y., Wang, W., Luo, X., Zhao, X., & Wang, X. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz246 · Cited by 81 · see citing works

Disabling a Type I-E CRISPR-Cas Nuclease with a Bacteriophage-Encoded Anti-CRISPR Protein

Pawluk, A., Shah, M. K., Mejdani, M., Calmettes, C., Moraes, T. F., Davidson, A. R., & Maxwell, K. L. (2017) · mBio · doi:10.1128/mbio.01751-17 · Cited by 80 · see citing works

Recent advances on extracellular vesicles in therapeutic delivery: Challenges, solutions, and opportunities

Lu, M., Xing, H., Yang, Z. L., Sun, Y., Yang, T., Zhao, X., Cai, C., Wang, D., & Ding, P. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.07.010 · Cited by 76 · see citing works

Golden Gate Assembly of CRISPR gRNA expression array for simultaneously targeting multiple genes

Vad‐Nielsen, J., Lin, L., Bolund, L., Nielsen, A. L., & Luo, Y. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2271-5 · Cited by 75 · see citing works

Genome-wide correlation analysis suggests different roles of CRISPR-Cas systems in the acquisition of antibiotic resistance genes in diverse species

Shehreen, S., Chyou, T., Fineran, P. C., & Brown, C. M. (2019) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2018.0384 · Cited by 75 · see citing works

Prevalence of CRISPR-Cas Systems and Their Possible Association with Antibiotic Resistance in Enterococcus faecalis and Enterococcus faecium Collected from Hospital Wastewater

Alduhaidhawi, A. H. M., AlHuchaimi, S. N., Mayah, T. A. A., Al-Ouqaili, M. T. S., Alkafaas, S. S., Muthupandian, S., & Saki, M. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s358248 · Cited by 75 · see citing works

Targeted-antibacterial-plasmids (TAPs) combining conjugation and CRISPR/Cas systems achieve strain-specific antibacterial activity

Reuter, A., Hilpert, C., Berne-Dedieu, A., Lematre, S., Gueguen, E., Launay, G., Bigot, S., & Lesterlin, C. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab126 · Cited by 73 · see citing works

Native CRISPR-Cas-Mediated Genome Editing Enables Dissecting and Sensitizing Clinical Multidrug-Resistant P. aeruginosa

Xu, Z., Li, M., Li, Y., Cao, H., Lu, M., Xu, Z., Higuchi, Y., Yamasaki, S., Nishino, K., Woo, P. C. Y., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.006 · Cited by 71 · see citing works

An Attenuated CRISPR-Cas System in Enterococcus faecalis Permits DNA Acquisition

Hullahalli, K., Rodrigues, M., Nguyen, U. T., & Palmer, K. L. (2018) · mBio · doi:10.1128/mbio.00414-18 · Cited by 70 · see citing works

Natural outer membrane permeabilizers boost antibiotic action against irradiated resistant bacteria

Farrag, H. A., Abdallah, N. A., Shehata, M. M. K., & Awad, E. M. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0561-6 · Cited by 70 · see citing works

CRISPR-Cas is associated with fewer antibiotic resistance genes in bacterial pathogens

Pursey, E., Dimitriu, T., Paganelli, F. L., Westra, E. R., & van Houte, S. (2021) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2020.0464 · Cited by 68 · see citing works

Coupling transcriptional activation of CRISPR–Cas system and DNA repair genes by Csa3a in Sulfolobus islandicus

Liu, T., Liu, Z., Ye, Q., Pan, S., Wang, X., Li, Y., Peng, W., Liang, Y., She, Q., & Peng, N. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx612 · Cited by 67 · see citing works

Bacterial resistance to CRISPR-Cas antimicrobials

Vazquez-Uribe, R., Rathmer, C., Jahn, L. J., Ellabaan, M. M. H., Li, S. S., & Sommer, M. O. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-96735-4 · Cited by 67 · see citing works

CRISPR-Cas influences the acquisition of antibiotic resistance in Klebsiella pneumoniae

Mackow, N., Shen, J., Adnan, M., Khan, A., Fries, B. C., & Diago‐Navarro, E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225131 · Cited by 66 · see citing works

Delivery of CRISPR-Cas systems using phage-based vectors

Fage, C., Lemire, N., & Moineau, S. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.11.012 · Cited by 66 · see citing works

The CRISPR-Cas systems were selectively inactivated during evolution of Bacillus cereus group for adaptation to diverse environments

Zheng, Z., Zhang, Y., Liu, Z., Dong, Z., Xie, C., Bravo, A., Soberón, M., Mahillon, J., Sun, M., & Peng, D. (2020) · The ISME Journal · doi:10.1038/s41396-020-0623-5 · Cited by 62 · see citing works

Presence of Type I-F CRISPR/Cas systems is associated with antimicrobial susceptibility in Escherichia coli

Aydin, S., Personne, Y., Newire, E., Laverick, R., Russell, O., Roberts, A. P., & Enne, V. I. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx137 · Cited by 61 · see citing works

CRISPR/Cas9 Assisted Multiplex Genome Editing Technique in Escherichia coli

Xu, F., Zhao, D., Zhang, X., Ding, X., & Bi, C. (2018) · Biotechnology Journal · doi:10.1002/biot.201700604 · Cited by 61 · see citing works

Exploiting CRISPR-Cas to manipulate Enterococcus faecalis populations

Hullahalli, K., Rodrigues, M., & Palmer, K. L. (2017) · eLife · doi:10.7554/elife.26664 · Cited by 59 · see citing works

Emergence and mechanism of carbapenem-resistant Escherichia coli in Henan, China, 2014

Liang, W., Liu, H., Duan, G., Zhao, Y., Chen, S., Yang, H., & Xi, Y. (2017) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2017.09.020 · Cited by 58 · see citing works

Reversal of mcr-1-Mediated Colistin Resistance in Escherichia coli by CRISPR-Cas9 System

Wan, P., Cui, S., Ma, Z.-B., Chen, L., Li, X., Zhao, R., Xiong, W., & Zeng, Z. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s244885 · Cited by 56 · see citing works

CRISPR-Cas, a Prokaryotic Adaptive Immune System, in Endodontic, Oral, and Multidrug-resistant Hospital-acquired Enterococcus faecalis

Burley, K. M., & Sedgley, C. (2012) · Journal of Endodontics · doi:10.1016/j.joen.2012.07.004 · Cited by 56 · see citing works

Latest Advances of Virology Research Using CRISPR/Cas9-Based Gene-Editing Technology and Its Application to Vaccine Development

Teng, M., Yao, Y., Nair, V., & Luo, J. (2021) · Viruses · doi:10.3390/v13050779 · Cited by 54 · see citing works

Molecular insights into antibiotic resistance - how a binding protein traps albicidin

Rostock, L., Driller, R., Grätz, S., Kerwat, D., von Eckardstein, L., Petras, D., Kunert, M., Alings, C., Schmitt, F., Friedrich, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05551-4 · Cited by 51 · see citing works

Identification and characterization of a direct activator of a gene transfer agent

Fogg, P. C. M. (2019) · Nature Communications · doi:10.1038/s41467-019-08526-1 · Cited by 51 · see citing works

Bacterial alginate regulators and phage homologs repress CRISPR–Cas immunity

Borges, A. L., Castro, B., Govindarajan, S., Solvik, T. A., Escalante, V., & Bondy‐Denomy, J. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0691-3 · Cited by 50 · see citing works

New-Generation Antibiotics for Treatment of Gram-Positive Infections: A Review with Focus on Endocarditis and Osteomyelitis

Bloem, A., Bax, H. I., Yusuf, E., & Verkaik, N. J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081743 · Cited by 48 · see citing works

The CRISPR-cas System Promotes Antimicrobial Resistance in Campylobacter Jejuni

Shabbir, M. A. B., Wu, Q., Shabbir, M. Z., Sajid, A., Ahmed, S., Sattar, A., Tang, Y., Li, J., Maan, M. K., Hao, H., et al. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0234 · Cited by 47 · see citing works

Association of Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) Elements with Specific Serotypes and Virulence Potential of Shiga Toxin-Producing Escherichia coli

Toro, M., Cao, G., Ju, W., Allard, M. W., Barrangou, R., Zhao, S., Brown, E. W., & Meng, J. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.03018-13 · Cited by 47 · see citing works

Association of CRISPR/Cas System with the Drug Resistance in Klebsiella pneumoniae

Wang, G., Song, G., & Xu, Y. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s253380 · Cited by 47 · see citing works

Role of CRISPR-Cas system on antibiotic resistance patterns of Enterococcus faecalis

Gholizadeh, P., Aghazadeh, M. H., Ghotaslou, R., Rezaee, M. A., Pirzadeh, T., Cui, L., Watanabe, S., Feizi, H., Kadkhoda, H., & Kafil, H. S. (2021) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-021-00455-6 · Cited by 45 · see citing works

Isolation, characterization and analysis of pro-inflammatory potential of Klebsiella pneumoniae outer membrane vesicles

Martora, F., Pinto, F., Folliero, V., Cammarota, M., Dell’Annunziata, F., Squillaci, G., Galdiero, M., Morana, A., Schiraldi, C., Giovane, A., et al. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.103719 · Cited by 45 · see citing works

High throughput nanoparticle tracking analysis for monitoring outer membrane vesicle production

Gerritzen, M. J. H., Martens, D. E., Wijffels, R. H., & Stork, M. (2017) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2017.1333883 · Cited by 44 · see citing works

The evolutionary dynamics of integrons in changing environments

Engelstädter, J., Harms, K., & Johnsen, P. J. (2016) · The ISME Journal · doi:10.1038/ismej.2015.222 · Cited by 43 · see citing works

Comparative Analysis of the Orphan CRISPR2 Locus in 242 Enterococcus faecalis Strains

Hullahalli, K., Rodrigues, M., Schmidt, B. D., Li, X., Bhardwaj, P., & Palmer, K. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138890 · Cited by 42 · see citing works

CRISPR as a strong gene editing tool

Shen, S., Loh, T. J., Shen, H., Zheng, X., & Shen, H. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.1.128 · Cited by 37 · see citing works

Development of a genomic site for gene integration and expression in Enterococcus faecalis

DebRoy, S., van der Hoeven, R., Singh, K. V., Gao, P., Harvey, B. R., Murray, B. E., & Garsin, D. A. (2012) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2012.04.011 · Cited by 36 · see citing works

CRISPR- cas system in the acquisition of virulence genes in dental-root canal and hospital-acquired isolates of Enterococcus faecalis

Gholizadeh, P., Aghazadeh, M. H., Ghotaslou, R., Rezaee, M. A., Pirzadeh, T., Lanotte, P., Ganbarov, K., Bastami, M., Yousefi, M., & Kafil, H. S. (2020) · Virulence · doi:10.1080/21505594.2020.1809329 · Cited by 35 · see citing works

CRISPR-Cas Technology: Emerging Applications in Clinical Microbiology and Infectious Diseases

Serajian, S., Ahmadpour, E., Oliveira, S. M. R., Pereira, M. D. L., & Heidarzadeh, S. (2021) · Pharmaceuticals · doi:10.3390/ph14111171 · Cited by 34 · see citing works

Expanding the catalog of cas genes with metagenomes

Zhang, Q., Doak, T. G., & Ye, Y. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1262 · Cited by 31 · see citing works

Three-Year Trends of Healthcare-Associated Infections and Antibiotic Use in Acute Care Hospitals: Findings from 2016–2018 Point Prevalence Surveys in Sicily, Italy

Barchitta, M., Maugeri, A., Rosa, M. C. L., Mastra, C. L., Murolo, G., & Agodi, A. (2020) · Antibiotics · doi:10.3390/antibiotics10010001 · Cited by 30 · see citing works

Dissemination of Linezolid Resistance Through Sex Pheromone Plasmid Transfer in Enterococcus faecalis

Zou, J., Tang, Z., Jia, Y., Liu, H., Chen, Y., Zhang, D., Zhao, J., Tang, Y., Zhang, J., & Xia, Y. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01185 · Cited by 30 · see citing works

Coevolving Plasmids Drive Gene Flow and Genome Plasticity in Host-Associated Intracellular Bacteria

Köstlbacher, S., Collingro, A., Halter, T., Domman, D., & Horn, M. (2020) · Current Biology · doi:10.1016/j.cub.2020.10.030 · Cited by 29 · see citing works

Potential of CRISPR/Cas system in the diagnosis of COVID-19 infection

Hillary, V. E., Savarimuthu Ignacimuthu, S. J., & Ceasar, S. A. (2021) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2021.1970535 · Cited by 25 · see citing works

Examining the role of protein structural dynamics in drug resistance in Mycobacterium tuberculosis

Shaw, D. J., Hill, R. E., Simpson, N., Husseini, F. S., Robb, K., Greetham, G. M., Towrie, M., Parker, A. W., Robinson, D., Hirst, J. D., et al. (2017) · Chemical Science · doi:10.1039/c7sc03336b · Cited by 25 · see citing works

Distribution of CRISPR-Cas Systems in Clinical Carbapenem-Resistant Klebsiella pneumoniae Strains in a Chinese Tertiary Hospital and Its Potential Relationship with Virulence

Liao, W., Liu, Y., Chen, C., Li, J., Du, F., Long, D., & Zhang, W. (2019) · Microbial Drug Resistance · doi:10.1089/mdr.2019.0276 · Cited by 24 · see citing works

New Insights Into Functions and Possible Applications of Clostridium difficile CRISPR-Cas System

Maikova, A. S., Severinov, K., & Soutourina, O. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01740 · Cited by 21 · see citing works

Characterization and comparison of CRISPR Loci in Streptococcus thermophilus

Hu, T., Cui, Y., & Qu, X. (2019) · Archives of Microbiology · doi:10.1007/s00203-019-01780-3 · Cited by 17 · see citing works

Antibiotic Resistance Patterns of Enterobacteriaceae Isolated from Patients with Healthcare-Associated Infections

Choi, Y. K., Byeon, E. J., Park, J. J., Lee, J., & Seo, Y. B. (2021) · Infection and Chemotherapy · doi:10.3947/ic.2021.0030 · Cited by 15 · see citing works

Genome editing of Francisella tularensis using (CRISPR-Cas9)

Southern, S. J., & Oyston, P. C. F. (2020) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2020.106004 · Cited by 5 · see citing works

[Development of CRISPR technology and its application in bone and cartilage tissue engineering].

Chen, G., Cheng, D., & Chen, B. (2019) · Europe PMC (PubMed Central) · doi:10.12122/j.issn.1673-4254.2019.12.19 · Cited by 3 · see citing works

Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review

Muteeb, G., Rehman, M. T., Shahwan, M. J., & Aatif, M. (2023) · Pharmaceuticals · doi:10.3390/ph16111615 · Cited by 1,238 · see citing works

CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance

Mayorga-Ramos, A., Zúñiga-Miranda, J., Carrera-Pacheco, S. E., Barba‐Ostria, C., & Guamán, L. P. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00649 · Cited by 223 · see citing works

Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms

Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 229 · see citing works

Molecular Aspects of the Functioning of Pathogenic Bacteria Biofilm Based on Quorum Sensing (QS) Signal-Response System and Innovative Non-Antibiotic Strategies for Their Elimination

Juszczuk‐Kubiak, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052655 · Cited by 162 · see citing works

The Challenge of Overcoming Antibiotic Resistance in Carbapenem-Resistant Gram-Negative Bacteria: “Attack on Titan”

Mancuso, G., Gaetano, S. D., Midiri, A., Zummo, S., & Biondo, C. (2023) · Microorganisms · doi:10.3390/microorganisms11081912 · Cited by 108 · see citing works

Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy

Dubey, A. K., & Mostafavi, E. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1259435 · Cited by 89 · see citing works

Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver disease

Saeed, H., Díaz, L. A., Gil‐Gómez, A., Burton, J. P., Bajaj, J. S., Romero‐Gómez, M., Arrese, M. A., Arab, J. P., & Khan, M. Q. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0811 · Cited by 82 · see citing works

Harnessing Engineered Microbial Consortia for Xenobiotic Bioremediation: Integrating Multi-Omics and AI for Next-Generation Wastewater Treatment

Renganathan, P., Gaysina, L. A., García-Gutiérrez, C., Puente, E. O. R., & Hernández, J. C. S. (2025) · Journal of Xenobiotics · doi:10.3390/jox15040133 · Cited by 85 · see citing works

CRISPR-Cas Systems in the Fight Against Antimicrobial Resistance: Current Status, Potentials, and Future Directions

Ahmed, M. M., Hassan, H. K., Okesanya, O. J., Ukoaka, B. M., Eshun, G., Mourid, M. R., Adigun, O. A., Ogaya, J. B., Mohamed, Z., & Lucero‐Prisno, D. E. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s494327 · Cited by 86 · see citing works

Advances in CRISPR-Cas technology and its applications: revolutionising precision medicine

Azeez, S. S., Hamad, R. S., Hamad, B., Shekha, M. S., & Bergsten, P. (2024) · Frontiers in Genome Editing · doi:10.3389/fgeed.2024.1509924 · Cited by 84 · see citing works

Alternative therapeutics to control antimicrobial resistance: a general perspective

Singha, B., Singh, V., & Soni, V. (2024) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2024.1385460 · Cited by 79 · see citing works

Innovative approaches to combat antibiotic resistance: integrating CRISPR/Cas9 and nanoparticles against biofilm-driven infections

Natanzi, A. S., Poudineh, M., Karimi, E., Khaledi, A., & Kashani, H. H. (2025) · BMC Medicine · doi:10.1186/s12916-025-04323-4 · Cited by 73 · see citing works

Antibiotic-Resistant Pseudomonas aeruginosa: Current Challenges and Emerging Alternative Therapies

Hu, M., & Chua, S. L. (2025) · Microorganisms · doi:10.3390/microorganisms13040913 · Cited by 72 · see citing works

Role of CRISPR-Cas systems and anti-CRISPR proteins in bacterial antibiotic resistance

Kadkhoda, H., Gholizadeh, P., Kafil, H. S., Ghotaslou, R., Pirzadeh, T., Rezaee, M. A., Nabizadeh, E., Feizi, H., & Aghazadeh, M. H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34692 · Cited by 63 · see citing works

Microbial Genome Editing with CRISPR–Cas9: Recent Advances and Emerging Applications Across Sectors

Dudeja, C., Mishra, A., Ali, A., Singh, P. P., & Jaiswal, A. K. (2025) · Fermentation · doi:10.3390/fermentation11070410 · Cited by 67 · see citing works

Detection of antimicrobial resistance via state-of-the-art technologies versus conventional methods

Elbehiry, A., Marzouk, E., Abalkhail, A., Abdelsalam, M. H., Mostafa, M. E., Alasiri, M., Ibrahem, M. D., Ellethy, A. T., Almuzaini, A. M., Aljarallah, S. N., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1549044 · Cited by 58 · see citing works

Critical perspectives on advancing antibiotic resistant gene (ARG) detection technologies in aquatic ecosystems

Nassereddine, Z., Opara, S., Coutinho, O., Qyteti, F., Book, R., Heinicke, M. P., Napieralski, J. A., & Tiquia-Arashiro, S. M. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.177775 · Cited by 53 · see citing works

Emerging applications of gene editing technologies for the development of climate-resilient crops

Chavhan, R. L., Jaybhaye, S. G., Hinge, V. R., Deshmukh, A. S., Shaikh, U. S., Jadhav, P. K., Kadam, U. S., & Hong, J. C. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1524767 · Cited by 43 · see citing works

Polymicrobial Biofilms: Interkingdom Interactions, Resistance and Therapeutic Strategies

Nithyanand, P., Boya, B. R., Lee, J., & Lee, J. (2025) · Microbial Biotechnology · doi:10.1111/1751-7915.70218 · Cited by 45 · see citing works

Molecular and bacteriological investigations for the co-existence CRISPR/Cas system and β-lactamases of types extended-spectrum and carbapenemases in Multidrug, extensive drug and Pandrug-Resistant Klebsiella pneumoniae

Owaid, H. A., & Al-Ouqaili, M. T. S. (2024) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2024.104022 · Cited by 38 · see citing works

Molecular characterization and genome sequencing of selected highly resistant clinical isolates of Pseudomonas aeruginosa and its association with the clustered regularly interspaced palindromic repeat/Cas system

Owaid, H. A., & Al-Ouqaili, M. T. S. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e41670 · Cited by 35 · see citing works

Novel Dietary Approach with Probiotics, Prebiotics, and Synbiotics to Mitigate Antimicrobial Resistance and Subsequent Out Marketplace of Antimicrobial Agents: A Review

Habteweld, H. A., & Asfaw, T. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s413416 · Cited by 33 · see citing works

Reinvigorating AMR resilience: leveraging CRISPR–Cas technology potentials to combat the 2024 WHO bacterial priority pathogens for enhanced global health security—a systematic review

Okesanya, O. J., Ahmed, M. M., Ogaya, J. B., Amisu, B. O., Ukoaka, B. M., Adigun, O. A., Manirambona, E., Adebusuyi, O., Othman, Z. K., Oluwakemi, O. G., et al. (2025) · Tropical Medicine and Health · doi:10.1186/s41182-025-00728-2 · Cited by 29 · see citing works

Engineering artificial microbial consortia for personalized gut microbiome modulation and disease treatment

Mkilima, T. (2025) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15352 · Cited by 26 · see citing works

CRISPR-Cas System: A New Dawn to Combat Antibiotic Resistance

Rafiq, M. S., Shabbir, M. A. B., Raza, A., Irshad, S., Asghar, A., Maan, M. K., Gondal, M. A., & Hao, H. (2024) · BioDrugs · doi:10.1007/s40259-024-00656-3 · Cited by 24 · see citing works

Beyond antibiotics: CRISPR/Cas9 triumph over biofilm-associated antibiotic resistance infections

Zuberi, A., Ahmad, N., Ahmad, H., Saeed, M., & Ahmad, I. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1408569 · Cited by 26 · see citing works

Updates on the Virulence Factors Produced by Multidrug-Resistant Enterobacterales and Strategies to Control Their Infections

Azam, M. W., Zarrilli, R., & Khan, A. U. (2023) · Microorganisms · doi:10.3390/microorganisms11081901 · Cited by 20 · see citing works

Mobile Genetic Elements as Central Drivers of Antimicrobial Resistance: Molecular Mechanisms, Evolutionary Ecology, One Health Implications and Control Strategies

Hossain, H., Ali, M. H., Ahmad, T., Sayeed, S. S. B., Sakib, M. A. N., Brishty, K. A., Saleh, M. S. J., Hosen, M. M., Ahmed, S., Ahmed, S., et al. (2026) · Antibiotics · doi:10.3390/antibiotics15040418 · Cited by 23 · see citing works

Antimicrobial sensitisers: Gatekeepers to avoid the development of multidrug-resistant bacteria

Wang, H., Yang, Y., Wang, S., Badawy, S., Arés, I., Martínez, M., López-Torres, B., Martínez‐Larrañaga, M., Wang, X., Anadón, A., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.03.031 · Cited by 22 · see citing works

The Genus Aeromonas in Aquaculture: A Comprehensive Review of Prevalence, Virulence, and Antibiotic Resistance With an Emphasis on Key Pathogenic Species

Tao, L., Gao, D., Liu, Y., Sun, W., & Shan, X. (2025) · Reviews in Aquaculture · doi:10.1111/raq.70097 · Cited by 21 · see citing works

Class 1 integrons and multiple mobile genetic elements in clinical isolates of the Klebsiella pneumoniae complex from a tertiary hospital in eastern China

Wang, L., Zhu, M., Yan, C., Zhang, Y., He, X., Wu, L., Xu, J., Lu, J., Bao, Q., Hu, Y., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.985102 · Cited by 20 · see citing works

Phage Therapy in Managing Multidrug-Resistant (MDR) Infections in Cancer Therapy: Innovations, Complications, and Future Directions

Mafe, A. N., & Büsselberg, D. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17070820 · Cited by 18 · see citing works

A Comprehensive Review of Molecular Mechanisms Leading to the Emergence of Multidrug Resistance in Bacteria

Jhalora, V., & Bist, R. (2024) · Indian Journal of Microbiology · doi:10.1007/s12088-024-01384-6 · Cited by 21 · see citing works

Immunomodulation in Non-traditional Therapies for Methicillin-resistant Staphylococcus aureus (MRSA) Management

Subbarayudu, S., Namasivayam, S. K. R., & Arockiaraj, J. (2024) · Current Microbiology · doi:10.1007/s00284-024-03875-7 · Cited by 17 · see citing works

Environmental antimicrobial resistance: key reservoirs, surveillance and mitigation under One Health

Zhang, H., Luo, Y., Zhu, X., & Ju, F. (2025) · Biocontaminant · doi:10.48130/biocontam-0025-0023 · Cited by 16 · see citing works

Opportunities for engineering outer membrane vesicles using synthetic biology approaches

Kelwick, R. J. R., Webb, A. J., & Freemont, P. S. (2023) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2023.21 · Cited by 17 · see citing works

Precision in Action: The Role of Clustered Regularly Interspaced Short Palindromic Repeats/Cas in Gene Therapies

Banda, A., Impomeni, O., Singh, A., Baloch, A. R., Hu, W., & Jaijyan, D. K. (2024) · Vaccines · doi:10.3390/vaccines12060636 · Cited by 16 · see citing works

A comprehensive review of advanced strategies to combat antimicrobial resistance

Behera, B., Singh, R. P., Sharma, K., Rai, A., Singh, S., & Balan, B. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04464-3 · Cited by 16 · see citing works

Genomic characterisation of generic Escherichia coli from food-producing animals and products of animal origin in South Africa

Malesa, R. P., Pierneef, R., Magwedere, K., Mafuna, T., & Matle, I. (2024) · Frontiers in Bacteriology · doi:10.3389/fbrio.2024.1432292 · Cited by 15 · see citing works

Combining Advanced Therapies with Alternative Treatments: A New Approach to Managing Antimicrobial Resistance?

Kaspute, G., Zebrauskas, A., Streckyte, A., Ivaškienė, T., & Prentice, U. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17050648 · Cited by 15 · see citing works

CRISPR-Cas Systems: Bridging Bacterial Immunity and Host Interactions

Joseph, C. E., Jain, A., Yaqub, M. O., & Edison, L. K. (2025) · Applied Microbiology · doi:10.3390/applmicrobiol5040118 · Cited by 14 · see citing works

Application of CRISPR-Cas System to Mitigate Superbug Infections

Rabaan, A. A., Fares, M. A. A., Almaghaslah, M., Alpakistany, T. A., Kaabi, N. A. M. A., Alshamrani, S., Alshehri, A. A., Almazni, I. A., Saif, A., Hakami, A. R., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11102404 · Cited by 14 · see citing works

Biotechnological Innovations to Combat Antimicrobial Resistance and Advance Global Health Equity

Rugarabamu, S., & Mwanyika, G. (2025) · Bacteria · doi:10.3390/bacteria4030046 · Cited by 12 · see citing works

Discerning the dissemination mechanisms of antibiotic resistance genes through whole genome sequencing of extended-spectrum beta-lactamase (ESBL)-producing E. coli isolated from veterinary clinics and farms in South Korea

Song, H., Yoo, J. S., & Unno, T. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.172068 · Cited by 12 · see citing works

CRISPR-Cas systems as next-generation antimicrobials: a systemic review of mechanisms, delivery strategies, and translational challenges

Wizrah, M. S. I. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1747931 · Cited by 11 · see citing works

Antimicrobial resistance expansion in pathogens: a review of current mitigation strategies and advances towards innovative therapy

Adefisoye, M. A., & Olaniran, A. O. (2023) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlad127 · Cited by 11 · see citing works

Phagetherapy updates: New frontiers against antibiotic resistance

Malik, S., Ahsan, O., Muhammad, K., Munawar, N., & Waheed, Y. (2025) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2024.00126 · Cited by 11 · see citing works

Inhibition of MurA Enzyme from Escherichia coli by Flavonoids and Their Synthetic Analogues

Frlan, R., Hrast, M., & Gobec, S. (2023) · ACS Omega · doi:10.1021/acsomega.3c04813 · Cited by 10 · see citing works

Pharmaceuticals and Personal Care Products in the Environment with Emphasis on Horizontal Transfer of Antibiotic Resistance Genes

Prasad, M. N. V., & Elchuri, S. V. (2022) · Chemia, Dydaktyka, Ekologia, Metrologia · doi:10.2478/cdem-2022-0005 · Cited by 9 · see citing works

Harnessing Ultrasonic Technologies to Treat Staphylococcus Aureus Skin Infections

Hulme, J. (2025) · Molecules · doi:10.3390/molecules30030512 · Cited by 9 · see citing works

Natural vs. genetically engineered microbiomes: understanding public attitudes for indoor applications and pathways for future engagement

Cummings, C. L., Landreville, K. D., & Kuzma, J. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1560601 · Cited by 9 · see citing works

CRISPR-Cas System, Antimicrobial Resistance, and Enterococcus Genus—A Complicated Relationship

Costache, C. A., Colosi, I. A., Țoc, D. A., Daian, K., Damacus, D., Botan, A., Toc, A. G., Pana, A. G., Panaitescu, P.-Ș., Neculicioiu, V. S., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12071625 · Cited by 8 · see citing works

Genomic analysis of multi-drug resistant coagulase-negative staphylococci from healthy humans and animals revealed unusual mechanisms of resistance and CRISPR-Cas system

Abdullahi, I. N., Lozano, C., Latorre-Fernández, J., Zarazaga, M., Stegger, M., & Torres, C. (2024) · International Microbiology · doi:10.1007/s10123-024-00577-9 · Cited by 8 · see citing works

Taking the temperature of the United States public regarding microbiome engineering

Cummings, C. L., Landreville, K. D., & Kuzma, J. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1477377 · Cited by 8 · see citing works

Probiogenomic analysis of Limosilactobacillus fermentum SD7, a probiotic candidate with remarkable aggregation abilities

Yaikhan, T., Wonglapsuwan, M., Pahumunto, N., Nokchan, N., Teanpaisan, R., & Surachat, K. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42451 · Cited by 8 · see citing works

Effects of Lactiplantibacillus plantarum LM1215 on Candida albicans and Gardnerella vaginalis

Bae, W., Lee, Y. J., Jo, S., Shin, S. L., Kim, T., Sohn, M., & Seol, H. (2024) · Yonsei Medical Journal · doi:10.3349/ymj.2023.0490 · Cited by 8 · see citing works

Association between the presence of CRISPR-Cas system genes and antibiotic resistance in Klebsiella pneumoniae isolated from patients admitted in Ahvaz teaching hospitals

Montazeri, E. A., Saki, M., Savari, M., Meghdadi, H., & Akrami, S. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-10018-7 · Cited by 8 · see citing works

Population and pan-genomic analyses of Staphylococcus pseudintermedius identify geographic distinctions in accessory gene content and novel loci associated with AMR

Zehr, J. D., Sun, Q., Ceres, K., Merrill, A., Tyson, G. H., Cerić, O., Guag, J., Pauley, S., McQueary, H. C., Sams, K. L., et al. (2025) · Applied and Environmental Microbiology · doi:10.1128/aem.00010-25 · Cited by 9 · see citing works

Genomic and Transcriptomic Analyses Reveal Multiple Strategies for Vibrio parahaemolyticus to Tolerate Sub-Lethal Concentrations of Three Antibiotics

Yang, L., Pan, Y., Wang, J., Zhao, T., Zhao, Y., Yingjie, P., & Chen, L. (2024) · Foods · doi:10.3390/foods13111674 · Cited by 7 · see citing works

Harnessing beneficial bacteria to remediate antibiotic-polluted agricultural soils: integrating source diversity, bioavailability modulators, and ecological impacts

Olanrewaju, O. S., & Bezuidenhout, C. C. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1635233 · Cited by 8 · see citing works

CRISPR–Cas systems as emerging tools for precision biofilm control for food safety: Mechanisms and applications

Rahman, M. A., Akter, S., Ashrafudoulla, M., Jung, S.-J., Rapak, M. T., & Ha, S. (2025) · Food Research International · doi:10.1016/j.foodres.2025.117803 · Cited by 7 · see citing works

mcr gene family evolution and structural mechanisms of colistin resistance: from mcr-1 to emerging variants

Mehmood, M. S., Marakkalage, U. K. R. K., Arif, T., Javaid, F., Abid, M. A., Shahid, M., Parvez, A., Saddique, M. N., & Ali, S. (2026) · Archives of Microbiology · doi:10.1007/s00203-026-04739-3 · Cited by 7 · see citing works

Deciphering the genetics of antagonism and antimicrobial resistance in Bacillus velezensis HU-91 by whole genome analysis

Wash, P., Yasmin, H., Ullah, H., Haider, W., Khan, N., Ahmad, A., Mumtaz, S., & Hassan, M. N. (2023) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2023.102954 · Cited by 8 · see citing works

Exploring the evolutionary links: Innate immunity in bacteria and eukaryotes

Abavisani, M., Faraji, S., Ansari, B., Ebadpour, N., Kesharwani, P., & Sahebkar, A. (2024) · Process Biochemistry · doi:10.1016/j.procbio.2024.08.023 · Cited by 6 · see citing works

CRISPR Genome Editing in Personalized Therapy for Oral and Maxillofacial Diseases: A Scoping Review

Dziedzic, A. M., Kubina, R., Skonieczna, M., Madej, M., Fiegler-Rudol, J., Abid, M. F., Nadhim, D., & Tanasiewicz, M. (2025) · Biomedicines · doi:10.3390/biomedicines13112745 · Cited by 6 · see citing works

CRISPR-Cas mediated targeting of resistance genes for combating ESKAPE pathogen infections: A Review

Khan, M. F., Javed, M., Kaur, J., Badwal, A. K., & Singh, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149180 · Cited by 6 · see citing works

Microbiome interactions: Acinetobacter baumannii biofilms as a co-factor in oral cancer progression

Pathoor, N. N., Ganesh, P. S., & Gopal, R. K. (2024) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-024-04208-3 · Cited by 6 · see citing works

抗生素抗性基因的传播机制及对策

韩, 爱. (2024) · Zìrán kēxué xuébào · doi:10.52810/cjns.2024.002 · Cited by 6 · see citing works

Therapeutic Interventions for Pseudomonas Infections in Cystic Fibrosis Patients: A Review of Phase IV Trials

Alqasmi, M. H. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216530 · Cited by 5 · see citing works

Harnessing advances in mechanisms, detection, and strategies to combat antimicrobial resistance

Thakur, R., Aggarwal, K., Sood, N., Kumar, A., Joshi, S., Jindal, P., Maurya, R., Patel, P., & Kurmi, B. D. (2025) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2025.179641 · Cited by 5 · see citing works

The environmental threat of macrolide resistance: mechanisms, dissemination pathways, and urgent mitigation strategies

Devi, A., Sharma, V. K., Shrivastav, D., & Singh, S. (2025) · Environmental Monitoring and Assessment · doi:10.1007/s10661-025-14786-w · Cited by 5 · see citing works

Nanocarrier-mediated CRISPR-Cas delivery: a novel approach against antibiotic-resistant superbugs

Almufarriji, F. M. (2026) · Saudi Pharmaceutical Journal · doi:10.1007/s44446-026-00064-4 · Cited by 5 · see citing works

Applications and Challenges of CRISPR-Cas Technology for the Detection of Antimicrobial Resistance Genes

Tang, W., Yang, N., & Shi, M. (2026) · Infection and Drug Resistance · doi:10.2147/idr.s578705 · Cited by 5 · see citing works

CRISPR/Cas‑mediated targeted gene editing of Streptococcus mutans: A promising approach for precision dentistry for the prevention and management of caries (Review)

Padaru, M., Shetty, P., Kini, A., & Bhat, R. (2025) · World Academy of Sciences Journal · doi:10.3892/wasj.2025.349 · Cited by 5 · see citing works

Unlocking Cellular Memory and Gene Regulatory Networks: Pioneering the Future of Therapeutic Innovations

Momin, M. S. A., Bhadra, J., Bhunia, D., Sannigrahi, A., & De, N. (2025) · Cells · doi:10.3390/cells14120903 · Cited by 5 · see citing works

Genetic Mechanism of Cassava Disease Resistance: From Traditional Breeding to CRISPR/Cas Application

Huang, W., & Hong, Z. (2024) · Genomics and Applied Biology · doi:10.5376/gab.2024.15.0007 · Cited by 5 · see citing works

Advancing Antibacterial Strategies: CRISPR-Phage-Mediated Gene Therapy Targeting Bacterial Resistance Genes

Patel, A. K., Singh, N., Sachan, N., & Chandra, P. (2025) · Current Gene Therapy · doi:10.2174/0115665232417037250916112841 · Cited by 5 · see citing works

Mechanistic basis of multidrug resistance: Current status, challenges, and potential solutions

Dakal, T. C., Dhakar, R., Ahuja, M., Gadi, B. R., & Sharma, N. K. (2025) · Journal of Medicine Surgery and Public Health · doi:10.1016/j.glmedi.2025.100224 · Cited by 4 · see citing works

Decolonizing the gut from multidrug-resistant bacteria: Current strategies and future perspectives

Mishra, A., & Juneja, D. (2026) · World Journal of Methodology · doi:10.5662/wjm.v16.i1.108646 · Cited by 4 · see citing works

Genomic Insights into Bacterial Antimicrobial Resistance Transmission and Mitigation Strategies

Barcan, A. S., Barcan, R. A., & Vamanu, E. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010304596240629102419 · Cited by 4 · see citing works

Validation of drug targets using molecular methodologies and enzymatic activity assays for validation of inhibitory potential

Khan, S., Anwar, S., Choudhury, A., Mohammad, T., & Hassan, M. I. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22222-1.00007-6 · Cited by 4 · see citing works

Disinfectant-driven selective gene expression and metabolic evolution: Unstable nitrite accumulation and enhanced anammox activity in mixotrophic partial denitrification/anammox system

Guo, Y., Gao, J., Zhang, Y., Xie, T., Xu, H., & Wang, Y. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.139553 · Cited by 4 · see citing works

Advances in CRISPR-Cas systems for human bacterial disease

Mathuria, A., Vora, C., Ali, N., & Mani, I. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.07.013 · Cited by 4 · see citing works

Omics-Based Approaches in Developing Treatments Against Antimicrobial Resistance

Wang, Z., Xie, W., Luo, D., Wang, L., Xu, Y., Rosenn, E. H., & Soni, V. (2024) · Springer eBooks · doi:10.1007/978-3-031-65986-7_12 · Cited by 3 · see citing works

CRISPR/Cas System-Based Genome Editing of Crops and Microbiome to Achieve Food and Nutrition Security

Chaudhary, A., Singh, R. K., Bisht, T., Verma, A., Sharma, A., Dahiya, P., Kaushik, N., & Bhatia, R. K. (2025) · Springer eBooks · doi:10.1007/978-981-96-3534-4_13 · Cited by 3 · see citing works

The potential of the microbiome as a target for prevention and treatment of carbapenem-resistant Enterobacteriaceae infections

Zhang, L., Xu, T., Chen, W., Chai, Y., Wu, Y., & Du, X. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1674534 · Cited by 3 · see citing works

Contribution of CRISPR/Cas9 technology in gene editing and its potential therapeutic benefits in combating antimicrobial-resistant bacteria: a narrative review

Teffera, Z. H., Tegegne, B. A., Adugna, A., Belew, H., Amare, G. A., Abebaw, D., Atnaf, A., Mesganaw, B., Enchalew, K., Belay, W. Y., et al. (2026) · Discover Applied Sciences · doi:10.1007/s42452-026-08632-y · Cited by 3 · see citing works

The Catalytic Activity and Micro‐Mechanisms of Reducible Metal Oxide Nanozymes in Relation to Their Antibacterial Efficacy

Coathup, M. J., Pugazhendhi, A. S., Brown, D., Neal, C. J., Ta, K. M., Kolanthai, E., Dhungana, B., Schwartzman, J. D., Molinari, M., & Seal, S. (2026) · Small · doi:10.1002/smll.202514882 · Cited by 3 · see citing works

CRISPR-driven strategies to disrupt methicillin-resistant Staphylococcus aureus biofilms: a review

Nuevo, J. J. M., Fortaleza, J. A. G., Cabuhat, K. S. P., Ong, C. J. N., Jalova, A. C., Mortel, F. A., & Bacalzo, G. D. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1784529 · Cited by 4 · see citing works

Giving Antibiotics a Second Chance: Evolutionary Trade-Offs and Phage-Driven Restoration of Antibiotic Susceptibility

Wójcicki, M., Cieślik, M., Górski, A., & Jończyk‐Matysiak, E. (2026) · BioDrugs · doi:10.1007/s40259-026-00789-7 · Cited by 3 · see citing works

Bacteriophage as cargo and its application in nanomedicine

Arivarasan, V. K., & Consul, C. (2023) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.03.024 · Cited by 3 · see citing works

Genome editing in Acinetobacter baumannii through enhanced natural transformation

Yilmaz, I., & Özbek, T. (2024) · Journal of Basic Microbiology · doi:10.1002/jobm.202300644 · Cited by 3 · see citing works

Challenges and Emerging Molecular Approaches in Combating Antimicrobial Resistance

Ynion, G. P. L., Rosal, C. J. P., Zulueta, A., Ordanel, A., & Caipang, C. M. A. (2024) · Journal of Bacteriology and Virology · doi:10.4167/jbv.2024.54.1.012 · Cited by 3 · see citing works

CRISPR/Cas9 in perspective: evaluating efficacy, delivery methods, and ethical challenges in genome editing

Dhara, C., Sah, H., Gantayat, S., Rajput, M., & Mishra, S. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11815-w · Cited by 3 · see citing works

Advanced Strategies in Gut Microbiota Modulation for Enhancing Livestock Health

Iduu, N. V., Chaudhary, D., Kade, A. E., & Bastola, R. K. (2025) · Agricultural sciences. · doi:10.5772/intechopen.1009774 · Cited by 2 · see citing works

Next-Generation Sensors Using Artificial Intelligence as Enabling Technologies for Biomedical and Healthcare Applications

Noorali, S., Baldwin, J. C., & Vaseashta, A. (2025) · Springer proceedings in physics · doi:10.1007/978-3-031-84809-4_17 · Cited by 2 · see citing works

Association of the existence of CRISPR-Cas system and antimicrobial resistance in multi-drug resistant Klebsiella pneumoniae in Egypt

Menofy, N. G. E., Payoumi, A. N., Eissa, M. A., & El-Sharif, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-26706-6 · Cited by 2 · see citing works

Antimicrobial resistance and gene therapy: emerging molecular strategies for a global health threat

Vitiello, A., Boccellino, M., Zovi, A., & Bassetti, M. (2026) · Gene Therapy · doi:10.1038/s41434-026-00613-5 · Cited by 2 · see citing works

CRISPR-Cas at a crossroads: from microbial immunity to precision biotechnology

Eliwa, A. I. A., & Eldahshan, M. M. (2026) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2026.2658465 · Cited by 2 · see citing works

Expanding the Microbial Genomic Landscape and Biotechnological Applications of CRISPR-Cas Systems

Singh, S., Tiwari, H., Singh, M., Gautam, V., Gautam, A., & Gautam, H. K. (2026) · Biology · doi:10.3390/biology15100748 · Cited by 2 · see citing works

CRISPR-Cas systems for antibiotic resistance

Shaw, R., & Dasgupta, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36388-7.00008-2

CRISPR-Cas System: A New Dawn to Combat Antibiotic Resistance

Rafiq, M. S., Shabbir, M. A. B., Raza, A., Irshad, S., Asghar, A., Maan, M. K., Gondal, M. A., & Hao, H. (2024) · BioDrugs · doi:10.1007/s40259-024-00656-3 · Cited by 24 · see citing works

Exploiting CRISPR/Cas system in controlling antibiotic resistance of bacteria

Gholizadeh, P., Faghfuri, E., Ganbarov, K., & Kafil, H. S. (2024) · BioSocial Health Journal. · doi:10.34172/bshj.20 · Cited by 1 · see citing works

Role of CRISPR-Cas systems and anti-CRISPR proteins in bacterial antibiotic resistance

Kadkhoda, H., Gholizadeh, P., Kafil, H. S., Ghotaslou, R., Pirzadeh, T., Rezaee, M. A., Nabizadeh, E., Feizi, H., & Aghazadeh, M. H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34692 · Cited by 63 · see citing works

From resistance to remedy: the role of clustered regularly interspaced short palindromic repeats system in combating antimicrobial resistance—a review

Raza, A., Fatima, P., Yasmeen, B., Rana, Z. A., & Ellakwa, D. E. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03509-6 · Cited by 13 · see citing works